By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Galena Biopharma  

310 N. State Street, Suite 208

Lake Oswego   Oregon  97034  U.S.A.
Phone: 1-503-400-7636 Fax: 1-503-400-6611


SEARCH JOBS


Industry
Pharmaceutical






Company News
Lincoln Park Doubles Down On Oncology With $55M Galena Biopharma  (GALE) Bet 11/21/2014 6:21:04 AM
Galena Biopharma  (GALE) Completes Enrollment In GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial 11/18/2014 11:55:00 AM
Galena Biopharma  (GALE) To Present At The Stifel 2014 Healthcare Conference 11/13/2014 10:38:11 AM
Galena Biopharma  (GALE) Doses First Patient In Phase 2 Clinical Trial With Neuvax(TM) (Nelipepimut-S) In Combination With Herceptin® (Trastuzumab) To Treat High-Risk HER2 3+ Or HER2 Gene-Amplified Breast Cancer Patients 11/11/2014 7:18:24 AM
Galena Biopharma  (GALE) Presents GALE-301 (Folate Binding Protein Immunotherapy) Phase 2a Clinical Trial Data At The Society For Immunotherapy Of Cancer (SITC) 29th Annual Meeting 11/7/2014 7:44:30 AM
Galena Biopharma  (GALE) Reports Third Quarter 2014 Results 11/4/2014 7:51:41 AM
Galena Biopharma  (GALE) To Present GALE-301 (Folate Binding Protein) Phase 2a Clinical Trial Data At The Society For The Immunotherapy Of Cancer (SITC) 29th Annual Meeting On Friday, November 7, 2014 11/4/2014 7:12:48 AM
Galena Biopharma  (GALE) To Report Third Quarter 2014 Financial Results On Monday, November 3, 2014 10/27/2014 9:57:32 AM
Galena Biopharma  (GALE) Receives Notice Of Allowance Of Improvement Patent For Neuvax® (nelipepimut-S) In Japan 10/14/2014 8:39:47 AM
Galena Biopharma  (GALE) Announces Notice Of Allowance Of U.S. Patent Application For Neuvax™ (Nelipepimut-S) Combination 10/8/2014 7:16:08 AM
12345678910...
//-->